Ruowen Ge Selected Research

Ruowen Ge Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 10/2002
3	Hypoxia (Hypoxemia) 01/2022 - 01/2009
3	Infarction (Infarctions) 03/2016 - 08/2004
3	Myocardial Infarction 03/2016 - 05/2006
2	Inflammation (Inflammations) 11/2023 - 01/2022
2	Lung Diseases (Lung Disease) 10/2022 - 01/2020
2	Acute Lung Injury 01/2022 - 07/2015
2	Pathologic Neovascularization 02/2011 - 07/2002
2	Human Influenza (Influenza) 04/2009 - 08/2008
2	Ischemia 07/2006 - 10/2004
1	Asthma (Bronchial Asthma) 11/2023
1	Respiratory Hypersensitivity 11/2023
1	COVID-19 09/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Emphysema 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Pulmonary Edema 01/2022
1	Kidney Neoplasms (Kidney Cancer) 05/2020
1	Hematologic Neoplasms (Hematological Malignancy) 07/2018
1	Hypertrophy 01/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2016
1	Atherosclerotic Plaque (Atheroma) 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Atherosclerosis 01/2016
1	Arthritis (Polyarthritis) 07/2013
1	Experimental Melanoma 07/2013
1	Carcinogenesis 09/2012
1	Hepatocellular Carcinoma (Hepatoma) 01/2010
1	Influenza in Birds (Avian Flu) 04/2009
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2006
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2002

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
4	Endoplasmic Reticulum Chaperone BiPIBA 05/2020 - 07/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012 - 07/2002
3	Metalloproteases (Metalloproteinases)IBA 01/2022 - 07/2013
3	ThrombospondinsIBA 01/2022 - 07/2013
3	DisintegrinsIBA 01/2022 - 07/2013
3	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 01/2016
3	Peptides (Polypeptides)IBA 01/2020 - 01/2018
2	CytokinesIBA 01/2022 - 01/2016
2	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 07/2013
2	Angiopoietin-1IBA 07/2006 - 10/2002
1	AdiponectinIBA 11/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	CollagenIBA 01/2022
1	ChemokinesIBA 01/2022
1	SmokeIBA 01/2022
1	Monoclonal AntibodiesIBA 11/2019
1	Biomarkers (Surrogate Marker)IBA 07/2018
1	LigandsIBA 07/2018
1	PeptidomimeticsIBA 07/2018
1	PlasminogenIBA 01/2018
1	Therapeutic UsesIBA 03/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2016
1	ManganeseIBA 03/2016
1	Superoxide DismutaseIBA 03/2016
1	Apolipoproteins E (ApoE)IBA 01/2016
1	LipidsIBA 01/2016
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2016
1	Cysteine (L-Cysteine)FDA Link 01/2016
1	CreatinineIBA 01/2016
1	ApolipoproteinsIBA 01/2016
1	Versicans (Versican)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 07/2013
1	ADAMTS4 ProteinIBA 07/2013
1	Endothelial Growth FactorsIBA 09/2012
1	Placenta Growth FactorIBA 09/2012
1	Thymidine PhosphorylaseIBA 09/2012
1	Angiogenesis InhibitorsIBA 02/2011
1	EndonucleasesIBA 04/2009
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2009
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 08/2008
1	Viral RNAIBA 08/2008
1	Angiogenic ProteinsIBA 06/2008
1	imidazole mustard (BIC)IBA 01/2007
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 07/2002

Therapy/Procedure

9	Therapeutics 09/2022 - 08/2008
3	Ligation 05/2006 - 08/2004
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2022
1	Intravenous Injections 01/2020
1	Intravenous Administration 07/2018
1	Intraperitoneal Injections 06/2018